Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179768 | SCV000232072 | benign | not specified | 2015-04-10 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000202996 | SCV000257704 | benign | Lynch syndrome | 2015-05-11 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000409009 | SCV000488169 | uncertain significance | Lynch syndrome 4 | 2016-02-19 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000179768 | SCV000601856 | benign | not specified | 2021-04-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000531203 | SCV000625679 | benign | Hereditary nonpolyposis colorectal neoplasms | 2017-06-16 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000582069 | SCV000691103 | benign | Hereditary cancer-predisposing syndrome | 2021-10-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000582069 | SCV000691104 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000409009 | SCV000743784 | likely benign | Lynch syndrome 4 | 2016-05-20 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000409009 | SCV000745195 | benign | Lynch syndrome 4 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582069 | SCV002662144 | benign | Hereditary cancer-predisposing syndrome | 2020-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV000409009 | SCV004019859 | benign | Lynch syndrome 4 | 2023-04-04 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. |
All of Us Research Program, |
RCV000202996 | SCV004822678 | benign | Lynch syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000409009 | SCV000745846 | likely benign | Lynch syndrome 4 | 2015-05-08 | no assertion criteria provided | clinical testing | |
Ding PR Lab, |
RCV001093662 | SCV001250843 | uncertain significance | Lynch syndrome 1 | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000179768 | SCV001739646 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000179768 | SCV001797548 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579468 | SCV001807365 | likely benign | not provided | no assertion criteria provided | clinical testing |